Subject: Update on Vaccine Law Suit.
A landmark ruling in the French appeal courts last week against UK vaccine manufacturer Glaxo SmithKline passed almost unnoticed by the British media. Yet potentially it has huge importance for the 3000 UK families now seeking to sue SmithKline and another vaccine company over damage they say was caused to their children by the measles, mumps and rubella (MMR) jab.
Although the French legal action involved the hepatitis B vaccine, which the appeal judges decided had triggered multiple sclerosis (MS) in two women, the significance to the UK triple jab case is two-fold.
Crucially, it is the first time a court has decided that while there are no scientific studies which either prove or disprove a causal link between the vaccine and illness - often an insurmountable barrier to litigation - courts can reach a decision based on "serious precise presumptions and similar evidence".
That is vital to the UK litigants, who while armed with a growing dossier of research suggesting links between vaccination and disease, so far have no study which proves the case one way or the other,
Secondly, a significant number of the UK claimants are alleging the triple vaccine caused devastating nerve-damaging conditions similar to MS - like Guillain-Barre syndrome and transverse myelitis. The assertion is that, as with the cases of autism, the vaccine triggers a peculiar autoimmune reaction in some susceptible children. In the cases of MS, Guillain-Barre and myelitis, it is said to cause the body to attack the protective myelin sheath that covers the nervous system, gradually stripping it away.
As the Eye has already reported, many of the children with rare regressive autism, which their families allege was triggered by the triple jab, have curiously been found to have the measles virus in their gut.
Also recent research from the US has found that some of the children with regressive autism also have myelin sheath damage.